Literature DB >> 10606981

Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid.

M J Bottomley1, N J Webb, C J Watson, L Holt, M Bukhari, J Denton, A J Freemont, P E Brenchley.   

Abstract

The aims of this study were (i) to determine whether PlGF, VEGF and PlGF/VEGF heterodimers are detected in synovial fluid (SF) and plasma samples from patients with a range of arthropathies; (ii) to describe whether any correlation exists between SF PlGF, VEGF and PlGF/VEGF heterodimer levels and the total and differential SF leucocyte counts; and (iii) to investigate the regulation of peripheral blood mononuclear cell (PBMC) VEGF secretion by stimuli relevant to inflammatory joints. PlGF, VEGF and PlGF/VEGF heterodimer levels were measured in the SF and plasma of patients with a range of arthropathies and normal controls by ELISA. Western blotting for PlGF was performed on SF from three patients with rheumatoid arthritis (RA) and primary inflammatory arthropathies. VEGF was quantified in cell culture supernatants after stimulation with lipopolysaccharide (LPS), PlGF or cobalt ions of PBMC isolated from RA patients and controls. PlGF and VEGF were detected in all SF samples. PlGF/VEGF heterodimers were detected in 10.2% of SF samples, most frequently in RA samples. Western blotting confirmed the presence of PlGF in RA SF. PlGF was detected in 52% of RA and 31% of control plasma samples, and VEGF was detected in 38% of RA and 38% of control plasma samples. PlGF/VEGF heterodimers were detected in 21% of RA samples and none of the control samples. In primary inflammatory arthropathy patients, SF PlGF and VEGF levels correlated significantly with the SF total leucocyte count and the neutrophil count. PlGF was the most potent inducer of PBMC VEGF production in both RA and control subjects. This is the first report of the detection of PlGF and PlGF/VEGF heterodimers in the SF of patients with inflammatory arthropathies, and we have shown for the first time that PlGF up-regulates PBMC VEGF production. PlGF may therefore play a key role in the production of VEGF in the inflammatory joint.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606981      PMCID: PMC1905543          DOI: 10.1046/j.1365-2249.2000.01097.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing.

Authors:  Y Cao; W R Ji; P Qi; A Rosin; Y Cao
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

2.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.

Authors:  Y Yamada; J Nezu; M Shimane; Y Hirata
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

3.  Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.

Authors:  M Ziche; D Maglione; D Ribatti; L Morbidelli; C T Lago; M Battisti; I Paoletti; A Barra; M Tucci; G Parise; V Vincenti; H J Granger; G Viglietto; M G Persico
Journal:  Lab Invest       Date:  1997-04       Impact factor: 5.662

4.  Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.

Authors:  J Lee; A Gray; J Yuan; S M Luoh; H Avraham; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Localisation of placenta growth factor (PIGF) in human term placenta.

Authors:  A Khaliq; X F Li; M Shams; P Sisi; C A Acevedo; M J Whittle; H Weich; A Ahmed
Journal:  Growth Factors       Date:  1996       Impact factor: 2.511

6.  Cloning and characterization of a novel human gene related to vascular endothelial growth factor.

Authors:  S Grimmond; J Lagercrantz; C Drinkwater; G Silins; S Townson; P Pollock; D Gotley; E Carson; S Rakar; M Nordenskjöld; L Ward; N Hayward; G Weber
Journal:  Genome Res       Date:  1996-02       Impact factor: 9.043

7.  The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.

Authors:  M Clauss; H Weich; G Breier; U Knies; W Röckl; J Waltenberger; W Risau
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

8.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

Authors:  D R Senger; S R Ledbetter; K P Claffey; A Papadopoulos-Sergiou; C A Peruzzi; M Detmar
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

9.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Authors:  B Barleon; S Sozzani; D Zhou; H A Weich; A Mantovani; D Marmé
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

10.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

Authors:  B Olofsson; K Pajusola; A Kaipainen; G von Euler; V Joukov; O Saksela; A Orpana; R F Pettersson; K Alitalo; U Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more
  27 in total

Review 1.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 2.  Skin wound healing modulation by macrophages.

Authors:  Mathieu P Rodero; Kiarash Khosrotehrani
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

3.  PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Authors:  Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby
Journal:  Am J Reprod Immunol       Date:  2017-06-20       Impact factor: 3.886

Review 4.  Role of placenta growth factor in cancer and inflammation.

Authors:  Ki Jo Kim; Chul Soo Cho; Wan Uk Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

Review 5.  Placental growth factor: What hematologists need to know.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Blood Rev       Date:  2016-08-27       Impact factor: 8.250

Review 6.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.

Authors:  H M C Shantha Kumara; J C Cabot; A Hoffman; M Luchtefeld; M F Kalady; N Hyman; D Feingold; R Baxter; R Larry Whelan
Journal:  Surg Endosc       Date:  2009-01-28       Impact factor: 4.584

8.  Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis.

Authors:  Mohammed A Akhavani; Leigh Madden; Ian Buysschaert; Branavan Sivakumar; Norbert Kang; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-05-08       Impact factor: 5.156

Review 9.  Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.

Authors:  Seung-Ah Yoo; Seung-Ki Kwok; Wan-Uk Kim
Journal:  Mediators Inflamm       Date:  2009-02-10       Impact factor: 4.711

10.  Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.